My presentation nicu


Published on

neonatal respiratory distress full term late pre term

Published in: Education, Health & Medicine
  • Be the first to comment

My presentation nicu

  1. 1. Respiratory Distress in the Term and Near – Term infant by : Ahmad Salama (Newborn Resident)
  2. 2. Introduction *One of the most common reasons for admission of term neonates to a NICU. *Main cause of morbidity and mortality in the newborn period. * The circumstances of the newborn's birth provide important clues to the diagnosis.
  3. 3. Infants at Risk for Developing Respiratory Distress Preterm Infants Infants with birth asphyxia Infants of Diabetic Mothers Infants born by Cesarean Section Infants born to mothers with fever, Prolonged ROM, foul-smelling amniotic fluid. Meconium in amniotic fluid.
  4. 4. Clicical Presentation Tachypnea (RR > 60/min) Nasal flaring Retraction Grunting Delayed or decreased air entry +/- Cyanosis +/- Desaturation
  5. 5. causes • Pulmonary. • Extra pulmonary
  6. 6. Pulmonary Causes
  7. 7. Neonatal Respiratory Distress Algorithm
  9. 9. • It’s transient respiratory signs persist for less than 4 hours. Due to: • Hypothermia (Surfactant function is temperature- dependent) • Acidosis
  10. 10. C/P: • The baby, near or at term • presents within the first 2–3 hours, commonly after being transferred to the postnatal ward with the mother. • The infant usually has tachypnea( respiratory rate of up to 80–100/min) • expiratory grunt. • mild sternal or intercostal recession • Cyanosis, if present, is relieved by administering 25–30% oxygen.
  11. 11. Ix :  CXR … ABG… CBC INFECTION SHOULD BE EXCLUDED Rx : • Antibiotics ( until culture results) • O2 therapy
  12. 12. Parenchymal Diseases 1-TRANSIENT TACHYPNEA OF THE NEWBORN (TTN)
  13. 13. o also known as RDS type 2 or Wet lung . o Relatively benign condition o self limited o The most common cause of neonatal respiratory distress. o constituting more than 40 percent of cases o 11 per 1,000 live births.. They are not at risk for other illnesses.
  14. 14. Risk factors: • Elective CS . • ♂. • Maternal Asthma . • maternal Diabetes Onset: • within 2 hours after delivery
  15. 15. pathophysiolgy Fetal lung Fluid • Amount:About 20 ml/kg near term • Rate of production :2-5 ml/kg/hr. • The presence of lung liquid is important for normal lung development; chronic drainage results in pulmonary hypoplasia. **lung liquid has a high chloride but low bicarbonate and protein Concentration. **The dominant force mediating lung liquid secretion is the secondary active transport of chloride ions from the interstitial space into the lung lumen. ****During labour and delivery, the concentration of adrenaline (epinephrine) increases and, as a consequence, lung liquid secretion ceases and resorption begins.
  16. 16. Management Most significant discriminatory findings are the onset of the illness and the degree of distress exhibited by the infant Symptoms can last from a few hours to two days TTN is a clinical diagnosis CXR   
  17. 17. Rx: • It is supportive with close observation because the condition is usually self limited. • Low flow supplemental oxygen may be necessary for several hours. (usually FIO2 < 40 %) • Oral furosemide (Lasix) has not been shown to significantly improve status and should not be given
  18. 18. Malignant TTN • Severe Hypoxic Respiratory Failure in LPT Infants • LPT + ECS Pulmonary Hypertension • Gradual increase in oxygen requirement and subsequent evidence of PPHN
  19. 19. 2-Respiratory Distress Syndrome (RDS)
  20. 20. • These infants are typically 34 to 37 weeks of gestation • RF : include maternal diabetes, multiple births ,Elective CS , perinatal asphyxia, cold stress, and infants whose siblings suffered from RDS. • Because their surfactant sufficiency is borderline and they have larger pulmonary reserves, affected infants may be able to cope without ventilation for longer than smaller preterm infants. Infants who have RDS may do well with nasal continuous positive airway pressure or may require ventilation.
  21. 21. 3- Meconium Aspiration Syndrome (MAS)
  22. 22. MAS is defined as respiratory distress in an infant born through meconium- stained amniotic fluid whose symptoms cannot otherwise be explained. ** POST-MATURE** ?? * 13 % MSAF  4-5 % develop MAS
  23. 23. **Meconium : is composed of desquamated cells, secretions, lanugo, water, bile pigments, pancreatic enzymes, and amniotic fluid. **It is sterile although when aspirated, is locally irritative, obstructive, and a medium for bacterial culture. **
  24. 24. occurs early in the first trimester of pregnancy . Fetal defecation slows after 16 weeks gestation and becomes infrequent by 20 weeks, concurrent with innervation of the anal sphincter. From approximately 20 to 34 weeks, fetal passage of meconium remains infrequent • Meconium passage may represent hypoxia or fetal distress in utero
  25. 25. Physiology **The passage of meconium from the fetus into amnion is prevented by lack of peristalsis (low motilin level), tonic contraction of the anal sphincter, terminal cap of viscous meconium. **MSAF may be a natural phenomenon that doesn’t indicate fetal distress but mature GI tract in post term fetus with increased motilin level. **Vagal stimulation by cord or head compression may be associated with passage of meconium in the absence of fetal distress.
  26. 26. Several investigators have suggested that most cases of meconium aspiration occur in utero when fetal gasping is initiated before delivery Meconium has been found distally as far as the alveoli in some stillborn infants and in some infants that die within hours of delivery. There is currently no way to distinguish between the infant who has developed MAS by intrauterine respiration or gasping and the infant who has developed MAS by inhalation of meconium at the first breaths after delivery
  27. 27. Risk factors for MSAF Maternal HT Maternal DM Maternal heavy cigarette smoking Maternal chronic respiratory or CV Dx Post term pregnancy Pre-eclampsia/eclampsia Oligohydramnios IUGR Poor biophysical profile Abnormal fetal HR pattern
  29. 29. MAS must be considered in any infant born through MSAF who develops symptoms of RD.
  30. 30. Clinical Presentation **Evidence of postmaturity: peeling skin, long fingernails, and decreased vernix. **The vernix, umbilical cord, and nails may be meconium-stained, depending upon how long the infant has been exposed in utero. **In general, nails will become stained after 6 hours and vernix after 12 to 14 hours of exposure.
  31. 31. **The chest typically appears barrel-shaped, with an increased anterior-posterior diameter caused by overinflation. **Auscultation reveals rales and rhonchi immediately after birth Some patients are asymptomatic at birth and develop worsening signs of respiratory distress as the meconium moves from the large airways into the lower tracheobronchial tree.
  32. 32. *Symptoms similar to infants with TTN, but the presentation may suggest a more severe condition. *Infants have greater degrees of tachypnea, retraction and lethargy immediately after delivery. *Some infants will have an asymptomatic period of several hours before respiratory distress become apparent. *Arterial Blood Gases will reveal more acidosis, hypercapnia and hypoxemia than in infants with TTN. * Hypoxia occurs because aspiration takes place in utero .
  33. 33. Complications Partial obstruction complete obstruction Surfactant destruction Chemical pneumonitis &Bacterial pneumonia Asphyxia PPHN
  34. 34. Cleary&Wiswell
  35. 35. The management of MAS remains a CHALLENGE. Goals: Increased oxygenation while minimizing the barotrauma (may lead to air leak) by minimal MAP and as short IT as possible. Prevent pulmonary hypertension. Successful transition from intrauterine to extrauterine life with a drop in pulmonary arterial resistance and an increase in pulmonary blood flow.
  36. 36. **intrapartum oropharyngeal suction before delivery of the body in all cases of MSAF ??? **Elective intubation and tracheal suction was a standard therapy in the past. X X **SURFACTANT ???!! (↓↓↓ use of ECMO or iNO ) ** HFOV
  37. 37. Surfactant for MAS in full term/near term infants?? Cochrane Database Syst Rev. 2007 Jul 18;(3):CD002054 El Shahed A, Dargaville P, Ohlsson A, Soll R. CONCLUSIONS: In infants with MAS, surfactant administration may reduce the severity of respiratory illness and decrease the number of infants with progressive respiratory failure requiring support with ECMO. The relative efficacy of surfactant therapy compared to, or in conjunction with, other approaches to treatment including inhaled nitric oxide, liquid ventilation, surfactant lavage and high frequency ventilation remains to be tested.
  38. 38. 4-Pneumonia
  39. 39. Pneumonia may be acquired in utero, during delivery (or perinatally), or postnatally in the nursery or at home. ** Early onset or Late onset **The definition of the pneumonia was based on the presence of PMNL in the alveoli or interstitium , although the presence of bacteria was not necessary for the definition.
  40. 40. Routes of Acquisition Early-onset pneumonia generally within three days of birth, is acquired from the mother by one of three routes: Intrauterine aspiration of infected amniotic fluid Transplacental transmission Aspiration during or after birth of infected amniotic fluid. Late-onset pneumonia , which occurs during hospitalization or after discharge, generally arises from organisms colonizing the hospitalized newborn or is nosocomially acquired from infected individuals or contaminated equipment..
  41. 41. RISK FACTORS 1-PROM >18 hrs (early onset) 2-Infants who require assisted ventilation.(LOS) 3-Anomalies of the airway (eg,TOF,CCAM) 4-Severe underlying disease 5- Prolonged hospitalization 6- Neurologic impairment resulting in aspiration 7-Nosocomial infections occasionally are traced to poor handwashing or overcrowding
  42. 42. CLINICAL MANIFESTATIONS Early-onset pneumonia commonly presents with respiratory distress beginning at or soon after birth. Infants may have associated lethargy, apnea, tachycardia and poor perfusion, sometimes progressing to septic shock. Some infants develop pulmonary hypertension. Other signs include temperature instability, metabolic acidosis, and abdominal distension. None of these signs is specific for pneumonia. .
  43. 43. Late-onset pneumonia is marked by changes in the overall condition of the newborn and can include nonspecific signs of apnea, tachypnea, poor feeding, abdominal distention, jaundice, emesis, respiratory distress, and circulatory collapse. Ventilator-dependent infants may have increased oxygen and ventilator requirements or purulent tracheal secretions
  44. 44. Diagnosis Because signs of pneumonia are nonspecific, any newborn infant with sudden onset of respiratory distress or other signs of illness should be evaluated for pneumonia and/or sepsis.
  45. 45. 1- CultureS 2-CXR : * Bilateral alveolar densities with air bronchograms are characteristic . *Irregular patchy infiltrates or occasionally a normal pattern also occur.
  46. 46. Congenital pneumonia is a severe disease that frequently results in either stillbirth or death within the first 24 hours after birth. Management includes oxygen therapy, ventilatory support, antibiotics,and often vasopressor support such as dopamine and dobutamine.
  47. 47. 5-Congenital Diaphragmatic Hernia (CDH)
  48. 48. CDH is a developmental abnormality of the diaphragm resulting in a defect that permits abdominal viscera to enter the chest. Usually the defect occurs before the 8th week of embryonic life. Posterolateral segments of the diaphragm and more often on the left side. Triad at DR : abdomen to be scaphoid. Air entry is reduced on the affected side, and the heart sounds are displaced.
  49. 49. TUBE + NGT Bagging with mask XXXXXXXX (ECMO), HFOV , delayed surgical repair, permissivehypercapnia, nitric oxide, surfactant administration,
  50. 50. 6- Pulmonary Air Leak syndromes
  51. 51. Comprise a spectrum of diseases with the same underlying pathophysiology. Pneumomediastinum, Pneumothorax, Pulmonary interstitial emphysema (PIEs) Pneumopericardium Overdistension of alveolar sacs or terminal airways leads to disruption of airway integrity, resulting in dissection of air into surrounding spaces.
  52. 52. Most commonly seen in neonates with lung disease who are on ventilatory support but can also occur spontaneously. The more severe the lung disease, the higher the incidence of pulmonary air leak. Risk Factors for Air Leak Syndromes Spontaneous 0.5% Ventilatory support 15-20% CPAP 5% Meconium staining / aspiration Surfactant therapy Vigorous resuscitation (bag ventilation)
  53. 53. Clinical Presentation of Neonates with Air Leak Syndromes: Respiratory distress or sudden deterioration of clinical course with alteration of vital signs and worsening of blood gases. Asymmetry of thorax is present in unilateral cases.
  54. 54. 7-Persistant Pulmonary Hypertension of the newborn (PPHN)
  55. 55. It is characterized by high resistance in the pulmonary arteries, which produces an obstruction of blood flow through the lungs and right-to-left shunting through the ductus arteriosus and/or foramen ovale. **IDIOPATHIC (OR) SECONDARY ** Near-term, term, or post term infants. Suspected with hypoxia refractory to conventional ventilation
  56. 56. Maladaptation of the pulmonary vascular bed— functional pulmonary vasoconstriction with normal structural development and anatomy (eg, MAS, cold stress, asphyxia, sepsis) Maldevelopment of the pulmonary vascular bed—abnormal pulmonary vascular structure resulting in excessive muscularization (eg, fetal ductal closure, congenital heart disease) Underdevelopment of the pulmonary vascular bed—decreased cross-sectional area of pulmonary vascular bed secondary to hypoplasia (eg, Potter’s syndrome, diaphragmatic hernia)
  57. 57. P a t h o p h y s i o l o g y : *The neonatal pulmonary vasculature is sensitive to changes in arterial oxygen tension (PaO2) and pH. With hypoxemia and acidemia, the pulmonary vasculature constricts, resulting in increased pulmonary vascular resistance. High pulmonary vascular resistance promotes blood flow away from the lungs through the ductus arteriosus into the systemic system and results in right-to-left shunting It also maintains higher right-sided pressures in the heart. When right atrial pressure is greater than left atrial pressure and pulmonary artery pressure is greater than systemic pressure, blood flow follows the path of least resistance through the foramen ovale and ductus arteriosus, again bypassing the lungs. This promotion of right-to-left shunting results in hypoxemia due to venous admixture. The cycle repeats as hypoxemia increases pulmonary vascular resistance, resulting in further intrapulmonary shunting, hypoxemia, and pulmonary vasoconstriction.
  58. 58. C l i n i c a l P r e s e n t a t i o n : Respiratory distress and cyanosis worsen despite high concentrations of inspired oxygen. Arterial blood gases demonstrate severe hypoxemia, normal or mildly elevated (PaCO2), and metabolic acidosis.
  59. 59. The diagnostic work-up for PPHN may include a hyperoxia/hyperventilation test and/or preductal and postductal PaO2 tests. With the hyperoxia/hyperventilation test, the infant is placed in 100% FiO2 and hyperventilated at rates > 100 BPM. An increase in PaO2 from < 50 mm Hg before the test to > 100 mm Hg after the test is indicative of PPHN. Preductal and postductal blood is sampled to demonstrate a right-to-left shunt through the ductal arteriosus. Blood is drawn simultaneously from a preductal site (right radial or either temporal artery) and postductal site (umbilical, femoral, or posterior tibial artery). In the hypoxemic infant, ductal shunting is demonstrated with a PaO2 difference > 15 to 20 mm Hg between the preductal and postductal sites. Pulse oximetry also demonstrates an arterial oxygen percent saturation (SaO2) difference between the right arm and the rest of the body and supports the diagnosis of PPHN. Diagnosis of PPHN can be made by demonstration of a shunt by two-dimensional echocardiogram
  60. 60. Severity of PPHN Oxygenation index (OI) can be used to measure severity of PPHN. Oxygenation Index: (Mean Airway Pressure x FiO2 x 100)/Pao2
  61. 61. Management : The goal of treatment is to correct hypoxemia and acidosis and promote pulmonary vascular dilation.
  62. 62. Rx: 1- O2: Pulm VD … avoid prolonged hyperoxiemia … 2- Assisted Ventilation : HyperVentilation PaCO2 in the range of 40 to 50 mmHg to minimize lung injury associated with high tidal volumes. 3-Sedation 4-Surfactant. 5-Circulatory Support ….. Vasopressors 6-Correction Of Acidosis ….. HCO3 7-iNO(OI >25) 8- ECMO (OI >40).